Schizophrenia

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · see citing works

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882 · see citing works

Synaptic Pruning by Microglia Is Necessary for Normal Brain Development

Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · see citing works

Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner

Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · see citing works

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · see citing works

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561 · see citing works

Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies

Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs050 · Cited by 2,436 · see citing works

Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies

Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356 · see citing works

A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder

van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009) · Psychological Medicine · doi:10.1017/s0033291708003814 · Cited by 2,343 · see citing works

Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality

McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280 · see citing works

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263 · see citing works

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224 · see citing works

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220 · see citing works

Rate of de novo mutations and the importance of father’s age to disease risk

Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134 · see citing works

Abnormal neural oscillations and synchrony in schizophrenia

Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120 · see citing works

Risks of all-cause and suicide mortality in mental disorders: a meta-review

Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115 · see citing works

A Systematic Review of Mortality in Schizophrenia: Is the Differential Mortality Gap Worsening Over Time?

Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065 · see citing works

Schizophrenia

van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971 · see citing works

Rethinking schizophrenia

Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783 · see citing works

Antipsychotic drug doses and neuroleptic/dopamine receptors

SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622 · see citing works

De novo mutations in schizophrenia implicate synaptic networks

Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617 · see citing works

The environment and schizophrenia

van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572 · see citing works

A polygenic burden of rare disruptive mutations in schizophrenia

Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385 · see citing works

Schizophrenia and migration: A meta-analysis and review

Cantor-Graae, E., & Selten, J.-P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.12 · Cited by 1,237 · see citing works

Genetic architectures of psychiatric disorders: the emerging picture and its implications

Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177 · see citing works

The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease

Stephan, A. H., Barres, B. A., & Stevens, B. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113810 · Cited by 1,113 · see citing works

The Diagnosis of Mental Disorders: The Problem of Reification

Hyman, S. E. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091532 · Cited by 1,052 · see citing works

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035 · see citing works

Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects

Haijma, S. V., Van Haren, N., Cahn, W., Koolschijn, P. C. M. P., Hulshoff Pol, H. E., & Kahn, R. S. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs118 · Cited by 1,012 · see citing works

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.

Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931 · see citing works

Schizophrenia and employment

Marwaha, S., & Johnson, S. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-004-0762-4 · Cited by 927 · see citing works

Excess early mortality in schizophrenia.

Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · see citing works

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial

Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896 · see citing works

Maternal immune activation and abnormal brain development across CNS disorders

Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880 · see citing works

Schizophrenia: an integrated sociodevelopmental-cognitive model

Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864 · see citing works

The Neurodevelopmental Hypothesis of Schizophrenia, Revisited

Fatemi, S. H., & Folsom, T. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn187 · Cited by 860 · see citing works

Mediation analysis with multiple mediators

VanderWeele, T., & Vansteelandt, S. (2014) · Epidemiologic Methods · doi:10.1515/em-2012-0010 · Cited by 858 · see citing works

CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics

Malhotra, D., & Sebat, J. (2012) · Cell · doi:10.1016/j.cell.2012.02.039 · Cited by 854 · see citing works

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia

Kirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.154 · Cited by 844 · see citing works

Functional requirement for class I MHC in CNS development and plasticity

Huh, G. S., Boulanger, L. M., Du, H., Riquelme, P. A., Brotz, T. M., & Shatz, C. J. (2000) · Science · doi:10.1126/science.290.5499.2155 · Cited by 828 · see citing works

Strong association of de novo copy number mutations with sporadic schizophrenia

Xu, B., Roos, J. L., Levy, S., van Rensburg, E. J., Gogos, J. A., & Karayiorgou, M. (2008) · Nature Genetics · doi:10.1038/ng.162 · Cited by 813 · see citing works

Cognition in schizophrenia: core psychological and neural mechanisms

Barch, D. M., & Ceaser, A. E. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.015 · Cited by 752 · see citing works

Gene–environment-wide association studies: emerging approaches

Thomas, D. C. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2764 · Cited by 694 · see citing works

Absolute Risk of Suicide After First Hospital Contact in Mental Disorder

Nordentoft, M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.113 · Cited by 689 · see citing works

The environment and susceptibility to schizophrenia

Brown, A. S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.003 · Cited by 664 · see citing works

A polygenic theory of schizophrenia.

Gottesman, I. I., & Shields, J. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.1.199 · Cited by 636 · see citing works

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

Meltzer, H. Y. (1989) · Psychopharmacology · doi:10.1007/bf00442554 · Cited by 604 · see citing works

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

Lieberman, J. A., Perkins, D. O., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593 · see citing works

The Kraepelinian dichotomy – going, going … but still not gone

Craddock, N., & Owen, M. J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.073429 · Cited by 587 · see citing works

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works

Somatic mutation, genomic variation, and neurological disease

Poduri, A., Evrony, G. D., Cai, X., & Walsh, C. A. (2013) · Science · doi:10.1126/science.1237758 · Cited by 584 · see citing works

Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register Study

Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582 · see citing works

Higher Risk of Offspring Schizophrenia Following Antenatal Maternal Exposure to Severe Adverse Life Events

Khashan, A. S., Abel, K. M., McNamee, R., Pedersen, M. G., Webb, R. T., Baker, P. N., Kenny, L. C., & Mortensen, P. B. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.20 · Cited by 576 · see citing works

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 576 · see citing works

Advancing Paternal Age and the Risk of Schizophrenia

Malaspina, D., Harlap, S., Fennig, S., Heiman, D., Nahon, D., Feldman, D., & Susser, E. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.361 · Cited by 562 · see citing works

Immune proteins in brain development and synaptic plasticity

Boulanger, L. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.001 · Cited by 555 · see citing works

Cognitive–behavioural therapy for the symptoms of schizophrenia: Systematic review and meta-analysis with examination of potential bias

Jauhar, S., McKenna, P. J., Radua, J., Fung, E., Salvador, R., & Laws, K. R. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.116285 · Cited by 517 · see citing works

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies

Fusar-Poli, P., Smieskova, R., Kempton, M. J., Ho, B. C., Andreasen, N. C., & Borgwardt, S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.001 · Cited by 512 · see citing works

Meta-Analysis of the Association of Urbanicity With Schizophrenia

Vassos, E., Pedersen, C. B., Murray, R. M., Collier, D. A., & Lewis, C. M. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs096 · Cited by 510 · see citing works

Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies

Khandaker, G. M., Zimbron, J., Lewis, G., & Jones, P. B. (2012) · Psychological Medicine · doi:10.1017/s0033291712000736 · Cited by 468 · see citing works

Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice

Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., Winter, C., Riva, M. A., Mortensen, P. B., Feldon, J., et al. (2013) · Science · doi:10.1126/science.1228261 · Cited by 459 · see citing works

Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies

Vita, A., De Peri, L., Deste, G., & Sacchetti, E. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.116 · Cited by 453 · see citing works

Update on Typical and Atypical Antipsychotic Drugs

Meltzer, H. Y. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-050911-161504 · Cited by 432 · see citing works

Induced pluripotent stem cells: the new patient?

Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 432 · see citing works

Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism

Brown, A. S. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22024 · Cited by 420 · see citing works

A Systematic Review and Meta-analysis of Northern Hemisphere Season of Birth Studies in Schizophrenia

Davies, G., Welham, J., Chant, D. C., Torrey, Ε. F., & McGrath, J. J. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007030 · Cited by 401 · see citing works

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 397 · see citing works

Redox dysregulation, neurodevelopment, and schizophrenia

Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works

Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12month and longer-term follow-ups

van der Gaag, M., Smit, F., Bechdolf, A., French, P., Linszen, D. H., Yung, A. R., McGorry, P., & Cuijpers, P. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.004 · Cited by 384 · see citing works

The Penetrance of Copy Number Variations for Schizophrenia and Developmental Delay

Kirov, G., Rees, E., Walters, J. T. R., Escott-Price, V., Georgieva, L., Richards, A. L., Chambert, K. D., Davies, G., Legge, S. E., Moran, J. L., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.022 · Cited by 368 · see citing works

Epidemiology-driven neurodevelopmental animal models of schizophrenia

Meyer, U., & Feldon, J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 366 · see citing works

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia

Ruderfer, D. M., Fanous, A. H., Ripke, S., McQuillin, A., Amdur, R. L., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Cross-Disorder Working Group of the Psychiatric Genomics Consortium, Gejman, P. V., O'Donovan, M. C., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.138 · Cited by 364 · see citing works

Neonatal Vitamin D Status and Risk of Schizophrenia

McGrath, J. J., Eyles, D. W., Pedersen, C. B., Anderson, C., Ko, P., Burne, T. H. J., Nørgaard‐Pedersen, B., HOUGAARD, D. M., & Mortensen, P. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.110 · Cited by 360 · see citing works

Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder

Lewandowski, K. E., Cohen, B. M., & Öngür, D. (2010) · Psychological Medicine · doi:10.1017/s0033291710001042 · Cited by 335 · see citing works

Immune signalling in neural development, synaptic plasticity and disease

Boulanger, L. M., & Shatz, C. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1428 · Cited by 334 · see citing works

Madness Explained: Psychosis and Human Nature

Lester, N. (2003) · BMJ · doi:10.1136/bmj.327.7422.1055-a · Cited by 322 · see citing works

Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis

Agerbo, E., Sullivan, P. F., Vilhjálmsson, B. J., Pedersen, C. B., Mors, O., Børglum, A. D., Hougaard, D. M., Hollegaard, M. V., Meier, S., Mattheisen, M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0346 · Cited by 319 · see citing works

Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1–ErbB4 and DISC1

Jaaro-Peled, H., Hayashi‐Takagi, A., Seshadri, S., Kamiya, A., Brandon, N. J., & Sawa, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.007 · Cited by 315 · see citing works

The prevalence of psychosis in epilepsy; a systematic review and meta-analysis

Clancy, M., Clarke, M. C., Connor, D., Cannon, M. D., & Cotter, D. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-75 · Cited by 314 · see citing works

The human brain in a dish: The promise of iPSC-derived neurons

Dolmetsch, R., & Geschwind, D. (2011) · Cell · doi:10.1016/j.cell.2011.05.034 · Cited by 313 · see citing works

Gone to Pot – A Review of the Association between Cannabis and Psychosis

Radhakrishnan, R., Wilkinson, S. T., & Dâ€TMSouza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 313 · see citing works

Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity

Hall, J., Trent, S., Thomas, K. L., O’Donovan, M. C., & Owen, M. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.011 · Cited by 290 · see citing works

PREGNANCY EXPERIENCE AND THE DEVELOPMENT OF BEHAVIOR DISORDER IN CHILDREN

Pasamanick, B., Rogers, M. E., & Lilienfeld, A. M. (1956) · American Journal of Psychiatry · doi:10.1176/ajp.112.8.613 · Cited by 286 · see citing works

Childhood infection and adult schizophrenia: A meta-analysis of population-based studies

Khandaker, G. M., Zimbron, J., Dalman, C., Lewis, G., & Jones, P. B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.023 · Cited by 257 · see citing works

A Comprehensive Assessment of Parental Age and Psychiatric Disorders

McGrath, J. J., Petersen, L., Agerbo, E., Mors, O., Mortensen, P. B., & Pedersen, C. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4081 · Cited by 253 · see citing works

Gene–Environment Interactions in Severe Mental Illness

Uher, R. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00048 · Cited by 251 · see citing works

Synapse elimination and learning rules co-regulated by MHC class I H2-Db

Lee, H., Brott, B. K., Kirkby, L. A., Adelson, J. D., Cheng, S., Feller, M. B., Datwani, A., & Shatz, C. J. (2014) · Nature · doi:10.1038/nature13154 · Cited by 228 · see citing works

Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain

Harvey, R. J., & Yee, B. K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3893 · Cited by 213 · see citing works

At Risk for Schizophrenic or Affective Psychoses? A Meta-Analysis of DSM/ICD Diagnostic Outcomes in Individuals at High Clinical Risk

Fusar‐Poli, P., Bechdolf, A., Taylor, M. J., Bonoldi, I., Carpenter, W. T., Yung, A. R., & McGuire, P. K. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs060 · Cited by 211 · see citing works

The Challenges and Promise of Neuroimaging in Psychiatry

Linden, D. E. J. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.014 · Cited by 206 · see citing works

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

Cabungcal, J.-H., Counotte, D. S., Lewis, E. M., Tejeda, H. A., Piantadosi, P., Pollock, C., Calhoon, G. G., Sullivan, E. M., Presgraves, E., Kil, J., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.028 · Cited by 204 · see citing works

A neurobiological hypothesis for the classification of schizophrenia: Type A (hyperdopaminergic) and type B (normodopaminergic)

Howes, O. D., & Kapur, S. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.138578 · Cited by 203 · see citing works

Meta-analysis of Paternal Age and Schizophrenia Risk in Male Versus Female Offspring

Miller, B., Messias, E., Miettunen, J., Alaräisänen, A., Järvelin, M., Koponen, H., Räsänen, P. K., Isohanni, M. K., & Kirkpatrick, B. W. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq011 · Cited by 200 · see citing works

Cognitive heterogeneity in schizophrenia

Joyce, E. M., & Roiser, J. P. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280ba4975 · Cited by 198 · see citing works

The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis

Benros, M. E., Eaton, W. W., & Mortensen, P. B. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.023 · Cited by 196 · see citing works

Rare Copy Number Variants<subtitle>A Point of Rarity in Genetic Risk for Bipolar Disorder and Schizophrenia</subtitle><alt-title>Rare Copy Number Variants</alt-title>

Grozeva, D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.25 · Cited by 192 · see citing works

Autoimmune diseases and infections as risk factors for schizophrenia

Benros, M. E., Mortensen, P. B., & Eaton, W. W. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06638.x · Cited by 190 · see citing works

Prediction and Prevention of Psychosis in Youth at Clinical High Risk

Addington, J., & Heinssen, R. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032511-143146 · Cited by 189 · see citing works

Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain

Malhotra, A. K. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.191 · Cited by 187 · see citing works

Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci

GROUP investigators, Børglum, A. D., Demontis, D., Grove, J., Pallesen, J., Hollegaard, M. V., Pedersen, C. B., Hedemand, A., Mattheisen, M., Uitterlinden, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.2 · Cited by 186 · see citing works

Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages.

Craddock, N. J., & Owen, M. J. (2007) · Europe PMC (PubMed Central) · Cited by 184 · see citing works

Parental socio-economic status and risk of first admission with schizophrenia

Byrne, M., Agerbo, E., Eaton, W. W., & Mortensen, P. B. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-004-0715-y · Cited by 184 · see citing works

Positive and Negative Symptoms and Jackson

Berríos, G. E. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790240097011 · Cited by 174 · see citing works

Psychological treatments for early psychosis can be beneficial or harmful, depending on the therapeutic alliance: an instrumental variable analysis

Goldsmith, L. P., Lewis, S. W., Dunn, G., & Bentall, R. P. (2015) · Psychological Medicine · doi:10.1017/s003329171500032x · Cited by 174 · see citing works

Full spectrum of psychiatric disorders related to foreign migration: a Danish population-based cohort study.

Cantor-Graae, E., & Pedersen, C. (2013) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2013.441 · Cited by 166 · see citing works

Head injury as risk factor for psychiatric disorders: a nationwide register-based follow-up study of 113,906 persons with head injury

Orlovska, S., Pedersen, M. S., Benros, M. E., Mortensen, P. B., Agerbo, E., & Nordentoft, M. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020190 · Cited by 165 · see citing works

Ten-Year Follow-up of the OPUS Specialized Early Intervention Trial for Patients With a First Episode of Psychosis

Secher, R. G., Hjorthoj, C. R., Austin, S. F., Thorup, A., Jeppesen, P., Mors, O., & Nordentoft, M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu155 · Cited by 158 · see citing works

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

Adkins, D. E., Åberg, K. A., McClay, J. L., Bukszár, J., Zhao, Z., Jia, P., Stroup, T. S., Perkins, D. O., McEvoy, J. P., Lieberman, J. A., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.14 · Cited by 152 · see citing works

A systematic review and meta‐analysis of the fertility of patients with schizophrenia and their unaffected relatives

Bundy, H., Stahl, D., & MacCabe, J. H. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01623.x · Cited by 150 · see citing works

Cortical circuit dysfunction and cognitive deficits in schizophrenia – implications for preemptive interventions

Lewis, D. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08156.x · Cited by 142 · see citing works

New Approaches to Psychiatric Diagnostic Classification

Owen, M. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.028 · Cited by 141 · see citing works

Environment and Schizophrenia: Review: The Wider Social Environment and Schizophrenia

Allardyce, J., & Boydell, J. E. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl008 · Cited by 140 · see citing works

Outcomes of public concern in schizophrenia

Kooyman, I., Dean, K., Harvey, S. B., & Walsh, E. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s29 · Cited by 138 · see citing works

Hospital Contacts With Infection and Risk of Schizophrenia: A Population-Based Cohort Study With Linkage of Danish National Registers

Nielsen, P. R., Benros, M. E., & Mortensen, P. B. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt200 · Cited by 129 · see citing works

CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1

Rees, E., Walters, J., Chambert, K., O'Dushlaine, C., Szatkiewicz, J., Richards, A. L., Georgieva, L., Mahoney‐Davies, G., Legge, S. E., Moran, J. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt540 · Cited by 129 · see citing works

Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia

Young, J. W., & Geyer, M. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.031 · Cited by 123 · see citing works

Schizophrenia: New Pathological Insights and Therapies

Jarskog, L. F., Miyamoto, S., & Lieberman, J. A. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.060904.084114 · Cited by 116 · see citing works

Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia

Hamshere, M. L., Stergiakouli, E., Langley, K., Martin, J., Holmans, P., Kent, L., Owen, M. J., Gill, M., Thapar, A., O’Donovan, M. C., et al. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.117432 · Cited by 108 · see citing works

Functional Consequences of Mutations in Postsynaptic Scaffolding Proteins and Relevance to Psychiatric Disorders

Ting, J. T., Peça, J., & Feng, G. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150442 · Cited by 106 · see citing works

Targeting glutamate synapses in schizophrenia

Field, J. R., Walker, A. G., & Conn, P. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.004 · Cited by 96 · see citing works

De Novo Rates and Selection of Schizophrenia-Associated Copy Number Variants

Rees, E., Moskvina, V., Owen, M. J., O'Donovan, M. C., & Kirov, G. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.011 · Cited by 94 · see citing works

Illuminating circuitry relevant to psychiatric disorders with optogenetics

Steinberg, E. E., Christoffel, D. J., Deisseroth, K., & Malenka, R. C. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.08.004 · Cited by 92 · see citing works

MHC class I modulates NMDA receptor function and AMPA receptor trafficking

Fourgeaud, L., Davenport, C. M., Tyler, C. M., Cheng, T. T., Spencer, M. B., & Boulanger, L. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914064107 · Cited by 89 · see citing works

Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology

McCarroll, S. A., & Hyman, S. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.046 · Cited by 87 · see citing works

A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness

Uher, R., Cumby, J., MacKenzie, L. E., Morash-Conway, J., Glover, J. M., Aylott, A., Propper, L., Abidi, S., Bagnell, A. L., Pavlová, B., et al. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0344-2 · Cited by 85 · see citing works

Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study

Laursen, T. M., Mortensen, P. B., MacCabe, J. H., Cohen, D., & Gasse, C. (2013) · Psychological Medicine · doi:10.1017/s003329171300216x · Cited by 78 · see citing works

Immunology of Schizophrenia

Müller, N. (2014) · NeuroImmunoModulation · doi:10.1159/000356538 · Cited by 77 · see citing works

The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research

Iyegbe, C. O., Campbell, D., Butler, A. W., Ajnakina, O., & Sham, P. C. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0823-2 · Cited by 76 · see citing works

Psychiatry in Transition: Outcomes of Mental Health Policy Shift in Italy

Barbato, A. (1998) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679809113122 · Cited by 70 · see citing works

Microglia: An Active Player in the Regulation of Synaptic Activity

Ji, K., Miyauchi, J. T., & Tsirka, S. E. (2013) · Neural Plasticity · doi:10.1155/2013/627325 · Cited by 67 · see citing works

The Neuroimmunology of Schizophrenia

Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 66 · see citing works

Implications of Genetic Findings for Understanding Schizophrenia

Owen, M. J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs103 · Cited by 58 · see citing works

Childhood Residential Mobility, Schizophrenia, and Bipolar Disorder: A Population-based Study in Denmark

Paksarian, D., Eaton, W. W., Mortensen, P. B., & Pedersen, C. B. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu074 · Cited by 48 · see citing works

The Epidemiology of Schizophrenia

Bradford, D. W. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.3.324 · Cited by 48 · see citing works

Prenatal and perinatal risk factors for schizophrenia

Cannon, M. D., Kendell, R. E., Susser, E., & Jones, P. B. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544118.009 · Cited by 36 · see citing works

Neuroimaging and plasticity in schizophrenia

Meyer-Lindenberg, A., & Tost, H. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139014 · Cited by 33 · see citing works

Is Prophylactic Psychiatry around the Corner? Combating Adolescent Oxidative Stress for Adult Psychosis and Schizophrenia

Sawa, A., & Seidman, L. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.028 · Cited by 31 · see citing works

Chromosomal microarray analysis—a routine clinical genetic test for patients with schizophrenia

Baker, K., Costain, G., Fung, W. L. A., & Bassett, A. S. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70308-6 · Cited by 25 · see citing works

The importance of father’s age to schizophrenia risk

Pedersen, C. B., McGrath, J. J., Mortensen, P. B., & Petersen, L. V. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.69 · Cited by 21 · see citing works

Human Stem Cells and Surrogate Tissues for Basic and Translational Study of Mental Disorders

Gamo, N. J., & Sawa, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.03.025 · Cited by 21 · see citing works

Preventing the Onset of Psychosis: Not Quite There Yet

HEINSSEN, R. K., & Insel, T. R. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu161 · Cited by 17 · see citing works

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04434-5 · Cited by 2,964 · see citing works

Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

GERAD1 Consortium, Pardiñas, A. F., CRESTAR Consortium, Holmans, P., Pocklington, A. J., Escott-Price, V., Ripke, S., Carrera, N., Legge, S. E., Bishop, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0059-2 · Cited by 1,552 · see citing works

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073 · see citing works

The Microbiota–Gut–Brain Axis in Psychiatric Disorders

Góralczyk-Bińkowska, A., Szmajda‐Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 534 · see citing works

Influence of gut microbiota on neuropsychiatric disorders

Cénit, M. C., Sanz, Y., & Codoñer‐Franch, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i30.5486 · Cited by 418 · see citing works

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

Davis, J., Eyre, H. A., Jacka, F. N., Dodd, S., Dean, O. M., McEwen, S. C., Debnath, M., McGrath, J. J., Maes, M. H. J., Amminger, G. P., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.017 · Cited by 358 · see citing works

Schizophrenia and the neurodevelopmental continuum:evidence from genomics

Owen, M. J., & O’Donovan, M. C. (2017) · World Psychiatry · doi:10.1002/wps.20440 · Cited by 326 · see citing works

The role of histone modifications: from neurodevelopment to neurodiseases

Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 321 · see citing works

Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk

Alnæs, D., Kaufmann, T., van der Meer, D., Córdova‐Palomera, A., Rokicki, J., Moberget, T., Bettella, F., Agartz, I., Barch, D. M., Bertolino, A., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0257 · Cited by 261 · see citing works

Cannabis use and risk of schizophrenia: a Mendelian randomization study

Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smıth, D. J., Pell, J. P., Sattar, N. A., Paré, G., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.252 · Cited by 262 · see citing works

Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders

van den Berg, M. M. J., Krauskopf, J., Ramaekers, J. G., Kleinjans, J. C. S., Prickaerts, J., & Briedé, J. J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101732 · Cited by 253 · see citing works

The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability

Singh, T., Walters, J. T. R., Johnstone, M., Curtis, D., Suvisaari, J., Torniainen, M., Rees, E., Iyegbe, C., Blackwood, D., McIntosh, A. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3903 · Cited by 231 · see citing works

Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders

Mitrea, L., Nemeș, S. A., Szabo, K., Teleky, B., & Vodnar, D. C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.813204 · Cited by 242 · see citing works

Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence

Smeland, O. B., Bahrami, S., Frei, O., Shadrin, A. A., O’Connell, K. S., Savage, J. E., Watanabe, K., Krull, F., Bettella, F., Steen, N. E., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0332-x · Cited by 223 · see citing works

Mitophagy in Human Diseases

Doblado, L., Lueck, C., Rey, C., Samhan-Arias, A. K., Priéto, I., Stacchiotti, A., & Monsalve, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083903 · Cited by 229 · see citing works

Phenotypic Landscape of Schizophrenia-Associated Genes Defines Candidates and Their Shared Functions

Thyme, S. B., Pieper, L. M., Li, E. H., Pandey, S., Wang, Y., Morris, N. S., Sha, C., Choi, J. W., Herrera, K. J., Soucy, E. R., et al. (2018) · Cell · doi:10.1016/j.cell.2019.01.048 · Cited by 205 · see citing works

Schizophrenia and influenza at the centenary of the 1918–1919 Spanish Influenza Pandemic: mechanisms of psychosis risk

Kępińska, A. P., Iyegbe, C. O., Vernon, A. C., Yolken, R., Murray, R. M., & Pollak, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00072 · Cited by 193 · see citing works

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

MacKenzie, N. E., Kowalchuk, C., Agarwal, S. M., Costa-Dookhan, K. A., Caravaggio, F., Gerretsen, P., Chintoh, A. F., Remington, G. J., Taylor, V. H., Müller, D. J., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00622 · Cited by 206 · see citing works

Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia

Notter, T., Coughlin, J. M., Gschwind, T., Weber-Stadlbauer, U., Wang, Y.-C., Kassiou, M., Vernon, A., Benke, D., Pomper, M., Sawa, A., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.248 · Cited by 195 · see citing works

Genomic findings in schizophrenia and their implications

Owen, M. J., Legge, S. E., Rees, E., Walters, J., & O’Donovan, M. C. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02293-8 · Cited by 189 · see citing works

Epigenetic Modifications in Schizophrenia and Related Disorders: Molecular Scars of Environmental Exposures and Source of Phenotypic Variability

Richetto, J., & Meyer, U. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.008 · Cited by 183 · see citing works

Spine dynamics in the brain, mental disorders and artificial neural networks

Kasai, H., Ziv, N. E., Okazaki, H., Yagishita, S., & Toyoizumi, T. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00467-3 · Cited by 180 · see citing works

Clozapine as a Model for Antipsychotic Development

Nucifora, F. C., Mihaljevic, M. M., Lee, B. J., & Sawa, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0552-9 · Cited by 174 · see citing works

Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders

Dash, S., Syed, Y. A., & Khan, M. R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.880544 · Cited by 179 · see citing works

Omega-3 fatty acids and mental health

Lange, K. W. (2020) · Global Health Journal · doi:10.1016/j.glohj.2020.01.004 · Cited by 183 · see citing works

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma

Coughlin, J. M., Wang, Y., Ambinder, E. B., Ward, R. E., Minn, I., Vranešić, M., Kim, P. K., Ford, C. N., Higgs, C. P., Hayes, L. N., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.40 · Cited by 169 · see citing works

Kmt1e regulates a large neuron-specific topological chromatin domain

Jiang, Y., Loh, Y., Rajarajan, P., Hirayama, T., Liao, W., Kassim, B. S., Javidfar, B., Hartley, B., Kleofas, L., Park, R. B., et al. (2017) · Nature Genetics · doi:10.1038/ng.3906 · Cited by 128 · see citing works

Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study

Cheng, C.-M., Wh, C., Chen, M.-H., Tsai, C.-F., Su, T.-P., Li, C., Tsai, S.-J., Hsu, J.-W., Huang, K.-L., Lin, W.-C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.217 · Cited by 165 · see citing works

Integrative Brain Network and Salience Models of Psychopathology and Cognitive Dysfunction in Schizophrenia

Menon, V., Palaniyappan, L. K., & Supekar, K. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.029 · Cited by 161 · see citing works

The P2X7 Receptor: Central Hub of Brain Diseases

Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162 · see citing works

Fetal programming of neuropsychiatric disorders

Faa, G., Manchia, M., Pintus, R., Gerosa, C., Marcialis, M. A., & Fanos, V. (2016) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21139 · Cited by 160 · see citing works

Environmental pollution and risk of psychotic disorders: A review of the science to date

Attademo, L., Bernardini, F., Garinella, R., & Compton, M. T. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.003 · Cited by 156 · see citing works

Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations

Lähteenvuo, M., & Tiihonen, J. (2021) · Drugs · doi:10.1007/s40265-021-01556-4 · Cited by 156 · see citing works

Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders

Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152 · see citing works

Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies

Kaar, S. J., Angelescu, I., Marques, T. R., & Howes, O. D. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02080-2 · Cited by 146 · see citing works

The glutathione cycle shapes synaptic glutamate activity

Sedlak, T., Paul, B., Parker, G. M., Hester, L., Snowman, A., Taniguchi, Y., Kamiya, A., Snyder, S., & Sawa, A. (2018) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1817885116 · Cited by 141 · see citing works

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta‐analyses

Belbasis, L., Köhler, C. A., Stefanis, N. C., Stubbs, B., van Os, J., Vieta, E., Seeman, M. V., Arango, C., Carvalho, A. F., & Εvangelou, Ε. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12847 · Cited by 148 · see citing works

Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders

Delgado‐Morales, R., Agís‐Balboa, R. C., Esteller, M., & Berdasco, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0365-z · Cited by 143 · see citing works

Impact of Advanced Paternal Age on Fertility and Risks of Genetic Disorders in Offspring

Kaltsas, A., Moustakli, E., Zikopoulos, A., Georgiou, I. A., Dimitriadis, F., Symeonidis, E. N., Markou, E., Michaelidis, T. M., Tien, D. M. B., Giannakis, I., et al. (2023) · Genes · doi:10.3390/genes14020486 · Cited by 149 · see citing works

Upper cortical layer–driven network impairment in schizophrenia

Batiuk, M. Y., Tyler, T., Dragičević, K., Mei, S., Rydbirk, R., Petukhov, V., Deviatiiarov, R. M., Sedmak, D., Frank, E., Feher, V., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn8367 · Cited by 141 · see citing works

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition

Colizzi, M., & Bhattacharyya, S. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0142-2 · Cited by 138 · see citing works

Vitamin A and Retinoic Acid in Cognition and Cognitive Disease

Wołoszynowska-Fraser, M. U., Kouchmeshky, A., & McCaffery, P. J. A. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-122319-034227 · Cited by 136 · see citing works

Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

Kim, S., Kang, H., Jhon, M., Kim, J., Lee, J., Walker, A. J., Agustini, B., Kim, J., & Berk, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00103 · Cited by 137 · see citing works

Specific Substantial Dysconnectivity in Schizophrenia: A Transdiagnostic Multimodal Meta-analysis of Resting-State Functional and Structural Magnetic Resonance Imaging Studies

Brandl, F., Avram, M., Weise, B., Shang, J., Simões, B., Bertram, T., Ayala, D. H., Penzel, N., Gürsel, D. A., Bäuml, J., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.003 · Cited by 131 · see citing works

Endocannabinoid System Components as Potential Biomarkers in Psychiatry

Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 134 · see citing works

Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis

Gao, X., Zhang, W., Li, Y., Xiao, Y., Liu, L., Liu, J., Li, S., Bo, T., Shah, C., Gong, Q., et al. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160219 · Cited by 132 · see citing works

Prenatal immune stress blunts microglia reactivity, impairing neurocircuitry

Hayes, L. N., An, K., Carloni, E., Li, F., Vincent, E., Trippaers, C., Paranjpe, M. D., Dölen, G., Goff, L. A., Ramos, A., et al. (2022) · Nature · doi:10.1038/s41586-022-05274-z · Cited by 131 · see citing works

Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode

Keating, D., McWilliams, S., Schneider, I., Hynes-Ryan, C., Cousins, G., Strawbridge, J., & Clarke, M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013881 · Cited by 130 · see citing works

Role of basal ganglia neurocircuitry in the pathology of psychiatric disorders

Macpherson, T., & Hikida, T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12830 · Cited by 131 · see citing works

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review

de Filippis, R., Carbone, E. A., Gaetano, R., Bruni, A., Pugliese, V., Segura‐Garcìa, C., & Fazio, P. D. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s202418 · Cited by 130 · see citing works

Whole genome sequencing in psychiatric disorders: the WGSPD consortium

(WGSPD), W. G. S. F. P. D., Sanders, S., Neale, B. M., Huang, H., Werling, D. M., An, J., Dong, S., Abecasis, G. R., Arguello, P. A., Blangero, J., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0017-9 · Cited by 125 · see citing works

Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants

Ostuzzi, G., Bertolini, F., Tedeschi, F., Vita, G., Brambilla, P., Fabro, L., Gastaldon, C., Papola, D., Purgato, M., Nosari, G., et al. (2022) · World Psychiatry · doi:10.1002/wps.20972 · Cited by 119 · see citing works

Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis

Penney, D., Sauvé, G., Mendelson, D., Thibaudeau, É., Moritz, S., & Lepage, M. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0277 · Cited by 126 · see citing works

Association Between Population Density and Genetic Risk for Schizophrenia

Colodro‐Conde, L., Couvy‐Duchesne, B., Whitfield, J. B., Streit, F., Gordon, S. D., Kemper, K. E., Yengo, L., Zheng, Z., Trzaskowski, M., de Zeeuw, E. L., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.1581 · Cited by 124 · see citing works

Psychosis: an autoimmune disease?

Al‐Diwani, A., Pollak, T. A., Irani, S. R., & Lennox, B. (2017) · Immunology · doi:10.1111/imm.12795 · Cited by 123 · see citing works

Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys

Bai, W., Liu, Z., Jiang, Y., Zhang, Q., Rao, W., Cheung, T. C. C., Hall, B. J., & Xiang, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01671-6 · Cited by 127 · see citing works

The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review

Dahoun, T., Trossbach, S. V., Brandon, N., Korth, C., & Howes, O. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.282 · Cited by 118 · see citing works

Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders

Morozova, A. Y., Zorkina, Y., Abramova, O. V., Pavlova, O., Ka, P., Soloveva, K., Volkova, M., Alekseeva, P. A., Andryshchenko, A., Kostyuk, G. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031217 · Cited by 126 · see citing works

Effects of High-Frequency Transcranial Magnetic Stimulation for Cognitive Deficit in Schizophrenia: A Meta-Analysis

Jiang, Y., Guo, Z., Xing, G., He, L., Peng, H., Du, F., McClure, M. A., & Mu, Q. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00135 · Cited by 120 · see citing works

Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia

Stedehouder, J., & Kushner, S. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.147 · Cited by 113 · see citing works

Attributable risk of hospital admissions for overall and specific mental disorders due to particulate matter pollution: A time-series study in Chengdu, China

Qiu, H., Zhu, X., Wang, L., Pan, J., Pu, X., Zeng, X., Zhang, L., Zhao, P., & Zhou, L. (2018) · Environmental Research · doi:10.1016/j.envres.2018.12.019 · Cited by 116 · see citing works

Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis

Kiburi, S. K., Molebatsi, K., Ntlantsana, V., & Lynskey, M. T. (2021) · Substance Abuse · doi:10.1080/08897077.2021.1876200 · Cited by 115 · see citing works

Alteration of the gut microbiome in first-episode drug-naive and chronic medicated schizophrenia correlate with regional brain volumes

Ma, X., Asif, H., Dai, L., He, Y., Zheng, W., Wang, D., Ren, H., Tang, J., Li, C., Jin, K., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.005 · Cited by 114 · see citing works

A deep learning based model using RNN-LSTM for the Detection of Schizophrenia from EEG data

Supakar, R., Satvaya, P., & Chakrabarti, P. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106225 · Cited by 110 · see citing works

Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations

Endres, D., Leypoldt, F., Bechter, K., Hasan, A., Steiner, J. H., Domschke, K., Wandinger, K., Falkai, P., Arolt, V., Stich, O., et al. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01113-2 · Cited by 109 · see citing works

Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review

Steardo, L., Carbone, E. A., de Filippis, R., Pisanu, C., Segura‐Garcìa, C., Squassina, A., Fazio, P. D., & Steardo, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00588 · Cited by 108 · see citing works

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes

Yang, C., Li, X., Wu, Y., Shen, Q., Zeng, Y., Xiong, Q., Wei, M., Chen, C., Liu, J., Huo, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03247-3 · Cited by 105 · see citing works

What genes are differentially expressed in individuals with schizophrenia? A systematic review

Merikangas, A. K., Shelly, M., Knighton, A., Kotler, N., Tanenbaum, N., & Almasy, L. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01420-7 · Cited by 104 · see citing works

The Lectin Pathway of the Complement System—Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems

Dobó, J., Kocsis, A., Farkas, B., Demeter, F., Cervenak, L., & Gál, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031566 · Cited by 109 · see citing works

mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders

Ryskalin, L., Limanaqi, F., Frati, A., Busceti, C. L., & Fornai, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082226 · Cited by 105 · see citing works

Analysis of gut mycobiota in first-episode, drug-naïve Chinese patients with schizophrenia: A pilot study

Zhang, X., Pan, L., Zhang, Z., Zhou, Y., Jiang, H., & Ruan, B. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112374 · Cited by 107 · see citing works

Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers

Khavari, B., & Cairns, M. J. (2020) · Cells · doi:10.3390/cells9081837 · Cited by 106 · see citing works

Human Accelerated Regions and Other Human-Specific Sequence Variations in the Context of Evolution and Their Relevance for Brain Development

Levchenko, А., Kanapin, A. A., Samsonova, A. A., & Gainetdinov, R. R. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx240 · Cited by 103 · see citing works

COVID-19 and psychosis risk: real or delusional concern?

Watson, C. J., Thomas, R. H., Solomon, T., Michael, B. D., Nicholson, T. R., & Pollak, T. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135491 · Cited by 103 · see citing works

Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia

Parellada, E., & Gassó, P. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01385-9 · Cited by 106 · see citing works

Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics?

Munawar, N., Ahsan, K., Muhammad, K., Ahmad, A., Anwar, M. A., Shah, I., Ameri, A. A., & Mughairbi, F. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147671 · Cited by 105 · see citing works

Atypical Lateralization in Neurodevelopmental and Psychiatric Disorders: What Is the Role of Stress?

Berretz, G., Wolf, O. T., Güntürkün, O., & Ocklenburg, S. (2020) · Cortex · doi:10.1016/j.cortex.2019.12.019 · Cited by 100 · see citing works

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

Habtewold, T. D., Rodijk, L. H., Liemburg, E. J., Sidorenkov, G. A., Boezen, H. M., Bruggeman, R., & Alizadeh, B. Z. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00919-x · Cited by 109 · see citing works

The Role of Cytokines in the Pathogenesis of Schizophrenia

Dawidowski, B., Górniak, A., Podwalski, P., Lebiecka, Z., Misiak, B., & Samochowiec, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173849 · Cited by 102 · see citing works

Global landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia

Breen, M. S., Dobbyn, A. L., Li, Q., Roussos, P., Hoffman, G. E., Stahl, E. A., Chess, A. J., Sklar, P. B., Li, J. B., Devlin, B., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0463-7 · Cited by 104 · see citing works

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies

Dedic, N., Dworak, H., Zeni, C. M., Rutigliano, G., & Howes, O. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413185 · Cited by 101 · see citing works

In vivo evidence of lower synaptic vesicle density in schizophrenia

Radhakrishnan, R., Skosnik, P. D., Ranganathan, M., Naganawa, M., Toyonaga, T., Finnema, S., Hillmer, A. T., Esterlis, I., Huang, Y., Nabulsi, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01184-0 · Cited by 100 · see citing works

The “polyenviromic risk score”: Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects

Padmanabhan, J. L., Shah, J. L., Tandon, N., & Keshavan, M. S. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.014 · Cited by 101 · see citing works

Genome-wide Association Analysis of Parkinson’s Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci

Smeland, O. B., Shadrin, A. A., Bahrami, S., Broce, I., Tesli, M., Frei, O., Wirgenes, K. V., O’Connell, K. S., Krull, F., Bettella, F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.026 · Cited by 100 · see citing works

Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders

Shobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 105 · see citing works

The role of norepinephrine in the pathophysiology of schizophrenia

Mäki-Marttunen, V., Andreassen, O. A., & Espeseth, T. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.038 · Cited by 97 · see citing works

An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders

Borrego-Ruiz, A., & Borrego, J. J. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110861 · Cited by 106 · see citing works

Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry

Nucifora, L. G., Tanaka, T., Hayes, L. N., Kim, M., Lee, B. J., Matsuda, T., Nucifora, F. C., Sedlak, T. W., Mojtabai, R., Eaton, W. W., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.178 · Cited by 94 · see citing works

Cancer mortality in patients with schizophrenia: systematic review and meta-analysis

Zhuo, C., Tao, R., Jiang, R., Lin, X., & Shao, M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195776 · Cited by 93 · see citing works

A Review of Default Mode Network Connectivity and Its Association With Social Cognition in Adolescents With Autism Spectrum Disorder and Early-Onset Psychosis

Nair, A., Jolliffe, M., Lograsso, Y. S. S., & Bearden, C. E. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00614 · Cited by 87 · see citing works

Oxidative Stress as a Common Key Event in Developmental Neurotoxicity

Nishimura, Y., Kanda, Y., Sone, H., & Aoyama, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6685204 · Cited by 89 · see citing works

The performance of artificial intelligence-driven technologies in diagnosing mental disorders: an umbrella review

Abd-Alrazaq, A. A., Alhuwail, D., Schneider, J., Toro, C. T., Ahmed, A., Alzubaidi, M. S., Alajlani, M., & Househ, M. S. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00631-8 · Cited by 90 · see citing works

Clozapine is associated with secondary antibody deficiency

Ponsford, M., Castle, D., Tahir, T. A., Robinson, R., Wade, W. N., Steven, R., Bramhall, K., Moody, M., Carne, E. M., Ford, C., et al. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.152 · Cited by 89 · see citing works

Interactions between the microbiota and enteric nervous system during gut-brain disorders

Fried, S. G., Wemelle, E., Cani, P. D., & Knauf, C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108721 · Cited by 90 · see citing works

Schizophrenia: One Name, Many Different Manifestations

Faden, J., & Citrome, L. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.05.005 · Cited by 89 · see citing works

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia

Caruso, G., Grasso, M., Fidilio, A., Tascedda, F., Drago, F., & Caraci, F. (2020) · Pharmaceuticals · doi:10.3390/ph13120457 · Cited by 88 · see citing works

The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study

Perry, B. I., Burgess, S., Jones, H. J., Zammit, S., Upthegrove, R., Mason, A. M., Day, F. R., Langenberg, C., Wareham, N. J., Jones, P. B., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003455 · Cited by 88 · see citing works

Polysialylation and disease

Sato, C., & Kitajima, K. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100892 · Cited by 87 · see citing works

Consistent Functional Connectivity Alterations in Schizophrenia Spectrum Disorder: A Multisite Study

Skåtun, K. C., Kaufmann, T., Doan, N. T., Alnæs, D., Córdova‐Palomera, A., Jönsson, E. G., Fatouros‐Bergman, H., Flyckt, L., Melle, I. S., Andreassen, O. A., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw145 · Cited by 83 · see citing works

P.2.002 Drug abuse in schizophrenia

Árias, F., Padín, J. J., Fernández, M., Luengo, M., & Hernández, M. S. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)88637-3

Raised incidence of schizophrenia in UK Afro-Caribbeans-clues to aetiology

Leff, J., Bhugra, D., & Mallett, R. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)95595-z

TC10D THE IMPORTANCE OF INTERVENING EARLY TO STOP THE PROGRESSION OF VIOLENCE AMONG MEN WITH SCHIZOPHRENIA

Hodgins, S. (2006) · Schizophrenia Research · doi:10.1016/s0920-9964(06)70092-5

Schizophrenia—An Overview

McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3360 · Cited by 1,481 · see citing works

Schizophrenia: from phenomenology to neurobiology

Wong, A. H. C., & Tol, H. H. M. V. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 282 · see citing works